4th LNP Immunogenicity and Toxicity Summit

Memo

Recent success of LNP safety has put the industry back in the spotlight. From personalized CRISPR treatments and Capstan's phase I trial initiation for autoimmune diseases, to Verve's recent clinical progress to lower cholesterol; these headlines have reignited the hope for LNPs to solve the biggest hurdles in drug delivery. The 4th LNP Immunogenicity and Toxicity returns in December, as an industry-dedicated virtual forum, bringing you the key updates on pre-clinical and clinical safety assessments and assays to effectively measure and monitor LNP safety for gene and cell therapies and vaccine applications. This year's exclusive one-day program will provide you with an entire day of scientific progress and technical insights into LNP mechanism of action, translational animal model approaches, and pharmacokinetic and dynamic studies to support the prediction, dosing strategy, and improve clinical effectiveness of pegylated and ionizable LNPs across all payloads. Log on to the platform from the comfort or your home or office and connect with 80+ fellow LNP experts spanning non-clinical and clinical safety, from immunology, toxicology, pharmacology, and bioanalytics to learn, share, and network virtually to support the development of safer LNPs for patients faster. URLs:Tickets: https://go.evvnt.com/3225691-2?pid=5569Brochure: https://go.evvnt.com/3225691-3?pid=5569 Date and Time: Wednesday, 03 December 2025 at 08:30 - 17:00 Venue details: Online Category: Conferences | Science, Health and Medicine | Pharmaceuticals | Drug Development Prices:Conference Only - Drug Developer Pricing: USD 1359.00,Conference Only - Academic and Non-Profit Pricing: USD 1079.00,Conference Only - Service Provider Pricing: USD 1919.00 Speakers: Aparajita Dutta, Head of Toxicology, Orna Therapeutics, Eric Dane, Principal Scientist, AstraZeneca, Haoyan Zhou, Director, Eli Lilly and Co., Joanna grudzinska, Senior Lead - Drug Metabolism and Pharmacokinetics Project, Bayer, Ka-Wai Wan, Senior Pharmaceutical Assessor, Medicines and Healthcare products Regulatory Agency, Lily Li, Senior Director, Eli Lilly and Co., Momei Yao, Senior Scientist - Immunogenicity, Orna Therapeutics, Shambhunath Choudhary, Associate Research Fellow and Pathology Therapeutic Area Lead, Pfizer, Soojin Kim, Senior Scientist, Genentech, Yogev Debbi, Co-Founder and Chief Executive Officer, Mana Bio, Zohreh Amoozgar, Senior Principal Scientist and Head of Lab, Sanofi